 |
|
|
| |
Physician Country of Birth and Hepatitis B Virus (HBV) Screening Practices of Asian-American Primary Care Providers (PCPs) Who Treat Asian Adults Living in the US
|
| |
| |
Reported by Jules Levin
AASLD Nov 3 2009 Boston
T Tran1, ASF Lok2, D Goodwin3, D Chu4, WR Kim5, R Fisher3, D Coombs3, EA Fagan3, F Rousseau3
1Geffen UCLA School of Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA; 2University of Michigan Medical Center, Ann Arbor, MI, USA;
3Gilead Sciences, Inc., Foster City, CA, USA; 4Albert Einstein College of Medicine, New York, NY, USA; 5Mayo Clinic College of Medicine, Rochester, MN, USA
BACKGROUND
Chronic HBV infection (CHB) disproportionately affects Asian-Americans
- Prevalence of ≥ 10%
- Incidence > 2 times that of Caucasian-Americans
Hepatocellular carcinoma (HCC) in Asian- Americans
- Risk is 2.7 times higher than in Caucasian-Americans
- Second highest cause of cancer mortality in Asian-American men
- Five-year survival rate is < 10%
Fewer than 25% of Asian-American patients with CHB have been diagnosed
40-60% of Asian-Americans with CHB go unscreened
OBJECTIVES
To determine the percentage of Asian patients living in the US screened for HBV infection by Asian-American primary care providers (PCPs)
To survey HBV screening practices of Asian-American PCPs, including barriers and motivators for screening
To determine if there are differences in HBV screening practices among Asian-American PCPs according to their country of birth
RESULTS
|
| |
|
|
|
|
|
